Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Yang, Lin ^a   Kuang, Huijuan ^a   Zhang, Wanyi ^a   Aguilar, Zoraida P ^b   Wei, Hua ^a   Xu, Hengyi ^a  

^a NANCHANG UNIVERSITY   (China)

^b Zystein LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD; METAL NANOPARTICLE; SILVER;

ANIMAL; ANTIBODY SPECIFICITY; BODY WEIGHT; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION PROFILING; IMAGE PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; LIVER; METABOLISM; MOUSE; TISSUE DISTRIBUTION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; BODY WEIGHT; GENE EXPRESSION PROFILING; GOLD; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; METAL NANOPARTICLES; MICE; ORGAN SPECIFICITY; SILVER; TISSUE DISTRIBUTION;

EID: 85020742376     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-03015-1     Document Type: Article

References (49)

1. Sau, T. K., Rogach, A. L., Jäckel, F., Klar, T. A., Feldmann, J. Properties and applications of colloidal nonspherical noble metal nanoparticles. Adv. Mater. 22, 1805-25, doi:10.1002/adma.200902557 (2010).
2. Dziendzikowska, K., et al. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J. Appl. Toxicol. 32, 920-928, doi:10.1002/jat.2758 (2012).
3. Zande, M., et al. Distribution, elimination, toxicity of silver nanoparticles and silver ions. ACS Nano 6, 7427-7442, doi:10.1021/nn302649p (2012).
4. Boisselier, E., Astruc, D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38, 1759-82, doi:10.1039/b806051g (2009).
5. Ghosh, P., Han, G., De, M., Kim, C. K., Rotello, V. M. Gold nanoparticles in delivery applications. Adv. Drug Deliver. Rev 60, 1307-15, doi:10.1016/j.addr.2008.03.016 (2008).
6. Balasubramanian, S. K., et al. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rat. Biomaterials 31, 2034-42, doi:10.1016/j.biomaterials.2009.11.079 (2010).
7. Lankoff, A., et al. The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells. Toxicol. Lett. 208, 197-213, doi:10.1016/j.toxlet.2011.11.006 (2012).
8. Li, J. J., et al. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv. Mater. 20, 138-42, doi:10.1002/adma.200701853 (2008).
9. Chueha, P. J., Lianga, R. Y., Leea, Y. H., Zenga, Z., Chuang, S. M. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J. Hazard. Mater. 264, 303-312, doi:10.1016/j.jhazmat.2013.11.031 (2014).
10. Kovács, D., et al. Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis. Sci. Rep. 6, doi:10.1038/srep27902 (2016).
11. Zhang, Y., et al. Silver nanoparticles decrease body weight and locomotor activity in adult male rats. Small 9, 1715-20, doi:10.1002/smll.201201548 (2013).
12. Sung, J. H., et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 20, 567-74, doi:10.1080/08958370701874671 (2008).
13. Hirn, S., et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm. 77, 407-16, doi:10.1016/j.ejpb.2010.12.029 (2011).
14. Lee, J. H., et al. Biopersistence of silver nanoparticles in tissues from Sprague-Dawley rats. Part. Fibre Toxicol. 10, 36, doi:10.1186/1743-8977-10-36 (2013).
15. Lasagna-Reeves, C., et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Bioph. Res. Co 393, 649-55, doi:10.1016/j.bbrc.2010.02.046 (2010).
16. Knudsen, K. B., et al. Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Nanotoxicology 8, 764-74, doi:10.3109/17435390.2013.829589 (2014).
17. Wan, J., et al. Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci. Rep. 5, doi:10.1038/srep11398 (2015).
18. Tak, Y. K., Pal, S., Naoghare, P. K., Rangasamy, S., Song, J. M. Shape-dependent skin penetration of silver nanoparticles: Does it really matter Sci. Rep. 5, doi:10.1038/srep16908 (2015).
19. Tiwari, D. K., Jin, T., Behari, J. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar Rats. Toxicol. Mech. Method 21, 13-24, doi:10.3109/15376516.2010.529184 (2011).
20. Kim, Y. S., et al. Twenty-eight-day oral toxicity, genotoxicity, gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20, 575-83, doi:10.1080/08958370701874663 (2008).
21. Xue, Y., et al. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J. Appl. Toxicol. 32, 890-99, doi:10.1002/jat.2742 (2012).
22. Johnston, H. J., et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 403, 28-46, doi:10.3109/10408440903453074 (2010).
23. Sung, J. H., et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 108, 452-61, doi:10.1093/toxsci/kfn246 (2009).
24. Sung, J. H., et al. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch. Toxicol. 86, 543-51, doi:10.1007/s00204-011-0759-1 (2012).
25. Lipka, J., et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31, 6574-81, doi:10.1016/j.biomaterials.2010.05.009 (2010).
26. De Jong, W. H., et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-19, doi:10.1016/j.biomaterials.2007.12.037 (2008).
27. Sonavane, G., Tomoda, K., Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloid surface B 66, 274-80, doi:10.1016/j.colsurfb.2008.07.004 (2008).
28. De Jong, W. H., et al. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials 34, 8333-43, doi:10.1016/j.biomaterials.2013.06.048 (2013).
29. Loeschner, K., et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 8, 18, doi:10.1186/1743-8977-8-18 (2011).
30. Su, C. K., Liu, H. T., Hsia, S. C., Sun, Y. C. Quantitatively profiling the dissolution and redistribution of silver nanoparticles in living rats using a knotted reactor-based differentiation scheme. Anal. Chem. 86, 8267-74, doi:10.1021/ac501691z (2014).
31. Kreyling, W. G., et al. In vivo integrity of polymer-coated gold nanoparticles. Nat. Nanotechnol 10, 619-623, doi:10.1038/nnano.2015.111 (2015).
32. Fraga, S., et al. Short-and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. Nanomed.-Nanotechnol 10, 1757-1766, doi:10.1016/j.nano.2014.06.005 (2014).
33. Semmler-Behnke, M., et al. Biodistribution of 1.4-A nd 18-nm gold particles in rats. Small 4, 2108-2111, doi:10.1002/smll.200800922 (2008).
34. Bar-Ilan, O., Albrecht, R. M., Fako, V. E., Furgeson, D. Y. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5, 1897-10, doi:10.1002/smll.200801716 (2009).
35. Su, Y., et al. In vivo distribution, pharmacokinetics, toxicity of aqueous synthesized cadmium-containing quantum dots. Biomaterials 32, 5855-62, doi:10.1016/j.biomaterials.2011.04.063 (2011).
36. Yang, L., et al. Size dpendent bodistribution and txicokinetics of ion oide mgnetic nnoparticles in mce. Nanoscale 7, 625-36, doi:10.1039/c4nr05061d (2015).
37. Zhang, Y., et al. Biodistribution, pharmacokinetics and toxicology Ag2S of near-infrared quantum dots in mice. Biomaterials 34, 3639-46, doi:10.1016/j.biomaterials.2013.01.089 (2013).
38. Nel, A., Xia, T., Mädler, L., Li, N. Toxic potential of materials at the nanolevel. Science 311, 622-27, doi:10.1126/science.1114397 (2006).
39. Nabeshi, H., et al. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology 23, 045101, doi:10.1088/0957-4484/23/4/045101 (2012).
40. Yang, Y., et al. Toxicity and biodistribution of aqueous synthesized ZnS and ZnO quantum dots in mice. Nanotoxicology 8, 107-16, doi:10.3109/17435390.2012.760014 (2014).
41. Tang, Y., et al. The role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots. Biomaterials 34, 8741-55, doi:10.1016/j.biomaterials.2013.07.087 (2013).
42. Ji, J. H., et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 19, 857-71, doi:10.1080/08958370701432108 (2007).
43. Park, K., et al. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch. Pharm. Res. 34, 153-58, doi:10.1007/s12272-011-0118-z (2011).
44. Choi, H. S., et al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165-70, doi:10.1038/nbt1340 (2007).
45. Tenzer, S., et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol 8, 772-781, doi:10.1038/nnano.2013.181 (2013).
46. Jedlovszky-Hajdu, A., et al. Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir 28, 14983-14991, doi:10.1021/la302446h (2012).
47. Sakulkhu, U., et al. Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci. Rep 4, 5020, doi:10.1038/srep05020 (2014).
48. Kuang, H., et al. Size dependent effect of ZnO nanoparticles on endoplasmic reticulum stress signaling pathway in murine liver. J. Hazard. Mater. 317, 119-126, doi:10.1016/j.jhazmat.2016.05.063 (2014).
49. Xu, L., et al. Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel. J. nanobiotechnol 10, 16, doi:10.1186/1477-3155-10-16 (2012).